“…Search term PubMed ("Mild cognitive impairment" OR "cognitive decline" OR "cognitive dysfunction" OR "mild cognitive deficit" OR "Alzheimer disease" OR AD OR amyloid OR "MCI" OR "amnestic mild cognitive impairment" OR "degenerative disease" OR "amyloid precursor protein A total of 45 studies were found. Of the 45, 15 studies discussed the hypothesised glymphatic system in relation to sleep [11,12,[23][24][25][26][27][28][29][30][31][32][33][34][35], 5 studies assessed the impact of PAP on brain fluid diffusivity in patients with OSAHS [36][37][38][39][40], 4 studies assessed the influence of PAP treatment on the level of AD biomarkers [29,31,41,42], 11 studies measured the impact of PAP treatment on cognitive function in OSAHS [1,4,14,[43][44][45][46][47][48][49][50] and 10 studies measured the impact of PAP treatment on cognitive function in OSAHS and aMCI/AD [7,8,17,20,21,[51][52][53][54]…”